【瑞康医药:拟收购浙江衡玖76.01%股权】瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。

金融界
21 Feb
瑞康医药公告,公司下属子公司吉祥山(山东)医学科技有限公司拟以现金方式收购关联方烟台衡悦健康科技合伙企业(有限合伙)持有的浙江衡玖医疗器械有限责任公司76.01%股权,交易金额为1.51亿元。浙江衡玖整体估值为1.99亿元,交易完成后,浙江衡玖将成为瑞康医药的合并报表子公司。此次交易构成关联交易,但不构成重大资产重组。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10